Tomasz Glinka
- Organic Chemistry top 5%
- Molecular Biology
- Pharmacology top 5%
- Molecular Medicine top 5%
- Pharmacology top 5%
- Co-authors
- Robert M. WilliamsE. KWASTMieczysław Ma̧koszaJuan F. Sanz‐CerveraScott J. HeckerJerzy T. WróbelMark E. FlanaganJanusz Popławski
- Topics
- Microbial Natural Products and Biosynthesis (6 papers)Antibiotic Resistance in Bacteria (5 papers)Quinazolinone synthesis and applications (5 papers)
- Journals
- Journal of the American Chemical SocietyJournal of Medicinal ChemistryAntimicrobial Agents and Chemotherapy
- Partner nations
- United StatesPoland
In The Last Decade
Tomasz Glinka
29 papers receiving 889 citations
Peers
Comparison fields: 5 of 77
- Organic Chemistry 506
- Molecular Biology 332
- Pharmacology 265
- Molecular Medicine 154
- Pharmacology 84
Countries citing papers authored by Tomasz Glinka
This map shows the geographic impact of Tomasz Glinka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomasz Glinka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomasz Glinka more than expected).
Fields of papers citing papers by Tomasz Glinka
This network shows the impact of papers produced by Tomasz Glinka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomasz Glinka. The network helps show where Tomasz Glinka may publish in the future.
Co-authorship network of co-authors of Tomasz Glinka
This figure shows the co-authorship network connecting the top 25 collaborators of Tomasz Glinka. A scholar is included among the top collaborators of Tomasz Glinka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomasz Glinka. Tomasz Glinka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 158 | |
| 2 | 23 | |
| 3 | 17 | |
| 4 | 7 | |
| 5 | 9 | |
| 6 | Novel cephalosporins for the treatment of MRSA infections. | 9 |
| 7 | 9 | |
| 8 | 16 | |
| 9 | 6 | |
| 10 | 8 | |
| 11 | 5 | |
| 12 | 11 | |
| 13 | 45 | |
| 14 | 51 | |
| 15 | 65 | |
| 16 | 20 | |
| 17 | 130 | |
| 18 | 65 | |
| 19 | 54 | |
| 20 | 40 |
About Tomasz Glinka
Tomasz Glinka is a scholar working on Molecular Medicine, Pharmacology and Organic Chemistry, having authored 29 papers that have together received 942 indexed citations. Recurring topics across this work include Microbial Natural Products and Biosynthesis (6 papers), Antibiotic Resistance in Bacteria (5 papers) and Quinazolinone synthesis and applications (5 papers). The work is most often cited by research in Molecular Medicine (154 citations), Organic Chemistry (506 citations) and Pharmacology (265 citations). Tomasz Glinka has collaborated with scholars based in United States and Poland. Frequent co-authors include Robert M. Williams, E. KWAST, Mieczysław Ma̧kosza, Juan F. Sanz‐Cervera, Scott J. Hecker, Jerzy T. Wróbel, Mark E. Flanagan, Janusz Popławski, Michael N. Dudley and David C. Griffith. Their work appears in journals such as Journal of the American Chemical Society, Journal of Medicinal Chemistry and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.